Abstract
Congenital hemangiopericytoma (HPC) is a rare mesenchymal tumor with less aggressive behavior and a more favorable prognosis than similar tumors in adults. Multifocal presentation is even less common than isolated HPC and hence its clinical and histologic recognition may be challenging. A newborn infant with multifocal congenital HPC causing severe deformity but with a favorable outcome after chemotherapy and surgical removal is reported.
© 2016 Wiley Periodicals, Inc.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / metabolism
-
Cyclophosphamide / therapeutic use
-
Dactinomycin / therapeutic use
-
Forearm
-
Hemangiopericytoma / diagnosis*
-
Hemangiopericytoma / drug therapy
-
Hemangiopericytoma / metabolism
-
Humans
-
Infant, Newborn
-
Magnetic Resonance Imaging
-
Male
-
Soft Tissue Neoplasms / diagnosis*
-
Soft Tissue Neoplasms / drug therapy
-
Soft Tissue Neoplasms / metabolism
-
Vincristine / therapeutic use
Substances
-
Biomarkers, Tumor
-
Dactinomycin
-
Vincristine
-
Cyclophosphamide